Abstract
Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.
| Original language | English (US) |
|---|---|
| Title of host publication | PanVascular Medicine, Second Edition |
| Publisher | Springer Berlin Heidelberg |
| Pages | 4211-4231 |
| Number of pages | 21 |
| ISBN (Print) | 9783642370786, 9783642370779 |
| DOIs | |
| State | Published - Jan 1 2015 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Pulmonary Hypertension Associated with Respiratory Disease. / Kolb, Todd Matthew; Hassoun, Paul M.
PanVascular Medicine, Second Edition. Springer Berlin Heidelberg, 2015. p. 4211-4231.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Pulmonary Hypertension Associated with Respiratory Disease
AU - Kolb, Todd Matthew
AU - Hassoun, Paul M
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.
AB - Pulmonary hypertension is a common complication of many chronic respiratory diseases. The mechanisms contributing to the development of pulmonary hypertension in this context are multiple and go beyond chronic hypoxic vasoconstriction. Outcomes are universally worsened when pulmonary hypertension complicates chronic respiratory disease. Treatment strategies target the underlying disease, as pulmonary vasodilator therapy has proven largely ineffective in trials to date. This chapter summarizes current understanding of the epidemiology, pathophysiology, and treatment of pulmonary hypertension as it relates to a spectrum of chronic respiratory diseases.
UR - http://www.scopus.com/inward/record.url?scp=84957016498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957016498&partnerID=8YFLogxK
U2 - 10.1007/978-3-642-37078-6_163
DO - 10.1007/978-3-642-37078-6_163
M3 - Chapter
AN - SCOPUS:84957016498
SN - 9783642370786
SN - 9783642370779
SP - 4211
EP - 4231
BT - PanVascular Medicine, Second Edition
PB - Springer Berlin Heidelberg
ER -